ACR 1.39% 7.3¢ acrux limited

lilly to acquire global license to axiron, page-14

  1. 1,538 Posts.
    lightbulb Created with Sketch. 5
    $50 million is enough to avoid any capital raisings and fund the pipeline, but not as much as I'd hoped for. With this structure, a lot is dependent on the commercialisation success of Axiron - as Evamist shows, products don't always live up to their promise.

    I'm happy to hold now. To push the market cap up over $500m, though, I think we'll need to see either approval and sales traction for Axiron or signs of progress with the rest of the pipeline.
 
watchlist Created with Sketch. Add ACR (ASX) to my watchlist
(20min delay)
Last
7.3¢
Change
0.001(1.39%)
Mkt cap ! $21.22M
Open High Low Value Volume
7.1¢ 7.3¢ 7.1¢ $9.252K 127.8K

Buyers (Bids)

No. Vol. Price($)
1 75344 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
7.3¢ 15232 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.